What is the recommended treatment for intestinal roundworm (Ascaris lumbricoides) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Roundworm (Ascaris lumbricoides) Treatment

For intestinal roundworm infection, treat with a single oral dose of albendazole 400 mg, mebendazole 500 mg, or ivermectin 200 μg/kg. All three options are equally effective as first-line therapy 1.

Treatment Algorithm

First-Line Options (Choose One):

  • Albendazole 400 mg PO - single dose
  • Mebendazole 500 mg PO - single dose
  • Ivermectin 200 μg/kg PO - single dose

All three medications demonstrate equivalent efficacy for uncomplicated ascariasis 1. The choice depends primarily on drug availability and cost considerations.

Special Clinical Scenarios:

Loeffler's Syndrome (Pulmonary Migration Phase):

  • If patient presents with fever, urticaria, wheeze, dry cough, or pulmonary infiltrates 1-2 weeks after exposure, treat with the standard single-dose regimen above
  • Consider retreatment 1 month after resolution of pulmonary symptoms to ensure adult worms are eliminated 1
  • Caution: Avoid corticosteroids unless strongyloidiasis has been definitively excluded, as steroids can precipitate hyperinfection syndrome 1

Intestinal Obstruction:

  • This represents a surgical emergency requiring exploration laparotomy
  • Administer antiparasitic treatment (albendazole or pyrantel pamoate) post-operatively 2

Biliary Obstruction:

  • More common in adults; requires endoscopic or surgical intervention
  • Follow with standard antiparasitic therapy 1

Key Clinical Considerations:

Diagnosis Confirmation:

  • Standard approach: Concentrated stool microscopy or fecal PCR 1
  • Early infection caveat: During the prepatent period (first 2-3 months), stool examinations will be negative as adult worms have not yet matured 3
  • If immature worms are expelled or clinical suspicion is high with negative stool studies, molecular diagnosis (PCR targeting Cox1 gene) can confirm the diagnosis 3

Treatment Efficacy:

  • Single-dose therapy achieves >90% cure rates for uncomplicated ascariasis 1
  • Quarterly dosing with mebendazole 100 mg has shown 92.5% cure rates in endemic areas with high reinfection pressure 4

Post-Treatment Monitoring:

  • In endemic areas with poor sanitation, reinfection commonly occurs due to lack of acquired immunity 5
  • Consider repeat stool examination if symptoms persist
  • In high-transmission settings, periodic retreatment every 3-6 months may be necessary 4, 6

Important Pitfalls to Avoid:

  1. Do not delay treatment waiting for stool confirmation if patient expels visible worms or has classic Loeffler's syndrome presentation 1

  2. Do not use corticosteroids for pulmonary symptoms without first excluding strongyloidiasis, as this can be fatal 1

  3. Do not assume treatment failure if eggs reappear in stool within weeks—this likely represents reinfection rather than drug resistance, especially in endemic areas 5

  4. Recognize surgical emergencies: Heavy worm burdens causing intestinal or biliary obstruction require surgical intervention before or concurrent with antiparasitic therapy 2, 7

  5. In children with severe manifestations (intestinal obstruction, recurrent GI bleeding), consider secondary bacterial infections and septic complications that may require aggressive supportive care beyond antiparasitic treatment 7

Empirical Treatment Context:

When eosinophilia is present with negative stool microscopy in travelers/migrants, empirical treatment with albendazole 400 mg plus ivermectin 200 μg/kg as single doses is reasonable to cover possible prepatent ascariasis, hookworm, and strongyloidiasis 1. However, exclude Loa loa infection before giving ivermectin in anyone who has traveled to endemic regions (Central/West Africa) 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.